|
|
||||||||
1. Recently it has been shown that injection of angiotensin II into the anterior diencephalon causes the rat to drink water. In the present experiments the dipsogenic action of a number of other substances including substances related to angiotensin was tested.
2. Injection of 0·001 Goldblatt u. renin into the angiotensin-sensitive region causes the water-replete rat to drink. Drinking is slower in onset and continues for longer than after injection of angiotensin II.
3. Synthetic tetradecapeptide renin substrate and angiotensin I were as effective as angiotensin II at causing water-replete rats to drink.
4.
-aspartic acid1-valine5-angiotensin II was also fully effective; but the D-arginine substituted octapeptide was much less effective.
5. The (2-8) heptapeptide retained about 50% of the dipsogenic activity of the octapeptide, whereas the absence of phenylalanine at the other end of the peptide chain in the (1-7) heptapeptide results in an inactive compound.
6. The (3-8) hexapeptide and the (4-8) pentapeptide, both of which have phenylalanine at the end of the chain, and the (1-4) and (5-8) tetrapeptide fragments of angiotensin II showed only a slight action on intake of water.
7. Kallikrein, bradykinin, adenosine-3'5-cyclic phosphate, vasopressin and oxytocin caused no drinking when injected into the angiotensin-sensitive region.
8. It is concluded that the requirements for the dipsogenic activity of angiotensin are the same as those for its other biological actions with the qualification that the precursor peptides are also active, presumably because they give rise to angiotensin II locally.
This article has been cited by other articles:
![]() |
J. Joyner, L. A. A. Neves, K. Stovall, C. M. Ferrario, and K. B. Brosnihan Angiotensin-(1-7) serves as an aquaretic by increasing water intake and diuresis in association with downregulation of aquaporin-1 during pregnancy in rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R1073 - R1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Joyner, L. A. A. Neves, J. P. Granger, B. T. Alexander, D. C. Merrill, M. C. Chappell, C. M. Ferrario, W. P. Davis, and K. B. Brosnihan Temporal-spatial expression of ANG-(1-7) and angiotensin-converting enzyme 2 in the kidney of normal and hypertensive pregnant rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R169 - R177. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Kokje, W. L. Wilson, T. E. Brown, V. T. Karamyan, J. W. Wright, and R. C. Speth Central Pressor Actions of Aminopeptidase-Resistant Angiotensin II Analogs: Challenging the Angiotensin III Hypothesis Hypertension, June 1, 2007; 49(6): 1328 - 1335. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Blume, C. Undeutsch, Y. Zhao, E. Kaschina, J. Culman, and T. Unger ANG III induces expression of inducible transcription factors of AP-1 and Krox families in rat brain Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2005; 289(3): R845 - R850. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Farjah, T. L. Washington, B. P. Roxas, D. L. Geenen, and R. S. Danziger Dietary NaCl Regulates Renal Aminopeptidase N: Relevance to Hypertension in the Dahl Rat Hypertension, February 1, 2004; 43(2): 282 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mustafa, Joo Hyung Lee, Siew Yeen Chai, A. L Albiston, S. G McDowall, and F. A. Mendelsohn Bioactive angiotensin peptides: focus on angiotensin IV Journal of Renin-Angiotensin-Aldosterone System, December 1, 2001; 2(4): 205 - 210. [PDF] |
||||
![]() |
G. H. M. Schoorlemmer, A. K. Johnson, and R. L. Thunhorst Circulating angiotensin II mediates sodium appetite in adrenalectomized rats Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2001; 281(3): R723 - R729. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Gironacci, M. Vatta, M. Rodriguez-Fermepin, B. E. Fernandez, and C. Pena Angiotensin-(1-7) Reduces Norepinephrine Release Through a Nitric Oxide Mechanism in Rat Hypothalamus Hypertension, June 1, 2000; 35(6): 1248 - 1252. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. T. Krebs, J. M. Hanesworth, M. F. Sardinia, R. C. Speth, J. W. Wright, and J. W. Harding A Novel Angiotensin Analog with Subnanomolar Affinity for Angiotensin-Converting Enzyme J. Pharmacol. Exp. Ther., April 1, 2000; 293(1): 260 - 267. [Abstract] [Full Text] |
||||
![]() |
J. T. FITZSIMONS Angiotensin, Thirst, and Sodium Appetite Physiol Rev, July 1, 1998; 78(3): 583 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Gironacci, P. S. Lorenzo, and E. Adler-Graschinsky Possible Participation of Nitric Oxide in the Increase of Norepinephrine Release Caused by Angiotensin Peptides in Rat Atria Hypertension, June 1, 1997; 29(6): 1344 - 1350. [Abstract] [Full Text] |
||||
![]() |
P. Li, M. C. Chappell, C. M. Ferrario, and K. B. Brosnihan Angiotensin-(1-7) Augments Bradykinin-Induced Vasodilation by Competing With ACE and Releasing Nitric Oxide Hypertension, January 1, 1997; 29(1): 394 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Brosnihan, P. Li, and C. M. Ferrario Angiotensin-(1-7) Dilates Canine Coronary Arteries Through Kinins and Nitric Oxide Hypertension, March 1, 1996; 27(3): 523 - 528. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |